Sponsored Links
| Merck Serono: Patient Enrollment Completed For Cilengitide's Pivotal Phase III Trial CENTRIC |
 |
 |
 |
| Medical News - Clinical Trials and Drug Trials | |||
|
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRICa has been completed... Read more: Clinical Trials / Drug Trials News From Medical News Today
|